Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Y Cahn

Showing results (101-110 of 178) with videos related to

Pageof 18
Sort By:
Blood|February 15, 1990
Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10)P Hervé, J Wijdenes, J P Bergerat, et al.
Transplantation|June 13, 1998
In vivo alloreactive potential of ex vivo-expanded primary T lymphocytesE Contassot, W Murphy, R Angonin, et al.
Bone Marrow Transplantation|January 1, 1991
The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patientsJ Y Cahn, P Bordigoni, G Souillet, et al.
Blood|April 15, 1995
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)A Devergie, D Blaise, M Attal, et al.
Blood|October 15, 1992
Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin?J Y Cahn, M Flesch, A Brion, et al.
The New England Journal of Medicine|December 7, 1995
Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphomaT Philip, C Guglielmi, A Hagenbeek, et al.
The New England Journal of Medicine|June 11, 1987
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphomaT Philip, J O Armitage, G Spitzer, et al.
Leukemia|November 13, 2010
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patientsE Nicolas, C Ramus, S Berthier, et al.
Cancer|October 20, 1999
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS GroupN Ifrah, F Witz, J P Jouet, et al.
Bone Marrow Transplantation|September 1, 1999
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, F Frassoni, et al.
Pageof 18

Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Blood|February 15, 1990
Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10)P Hervé, J Wijdenes, J P Bergerat, et al.
Transplantation|June 13, 1998
In vivo alloreactive potential of ex vivo-expanded primary T lymphocytesE Contassot, W Murphy, R Angonin, et al.
Bone Marrow Transplantation|January 1, 1991
The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patientsJ Y Cahn, P Bordigoni, G Souillet, et al.
Blood|April 15, 1995
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)A Devergie, D Blaise, M Attal, et al.
Blood|October 15, 1992
Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin?J Y Cahn, M Flesch, A Brion, et al.
The New England Journal of Medicine|December 7, 1995
Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphomaT Philip, C Guglielmi, A Hagenbeek, et al.
The New England Journal of Medicine|June 11, 1987
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphomaT Philip, J O Armitage, G Spitzer, et al.
Leukemia|November 13, 2010
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patientsE Nicolas, C Ramus, S Berthier, et al.
Cancer|October 20, 1999
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS GroupN Ifrah, F Witz, J P Jouet, et al.
Bone Marrow Transplantation|September 1, 1999
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, F Frassoni, et al.
Pageof 18